[1]
Smith, C. et al. 2022. Over-prescription of short-acting β2-agonists for asthma in South Africa: Results from the SABINA III study. African Journal of Thoracic and Critical Care Medicine. 28, 4 (Dec. 2022), 172–180. DOI:https://doi.org/10.7196/AJTCCM.2022.v28i4.220.